<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00095095</url>
  </required_header>
  <id_info>
    <org_study_id>NL04-90</org_study_id>
    <nct_id>NCT00095095</nct_id>
  </id_info>
  <brief_title>Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device</brief_title>
  <official_title>Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Spinal and Biologics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Spinal and Biologics</source>
  <brief_summary>
    <textblock>
      Lumbar spinal fusion is commonly performed as a &quot;last resort&quot; in patients with chronic low
      back pain caused by degenerative changes and instability of the spine. The aim of this study
      is to compare two fusion devices, which are used in spinal surgery in order to promote the
      fusion of two lumbar vertebrae.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar spinal fusion is commonly performed as a &quot;last resort&quot; in patients with chronic low
      back pain caused by degenerative changes and instability of the spine. The surgical treatment
      involves the removal of an intervertebral disc, and subsequently the union of the two
      adjacent intervertebral bodies, such that a bony connection is formed within time after
      surgery. Lumbar spinal fusion is being performed with increasing frequency. Many interbody
      fusion methods have been described. In recent years, several types of fusion cages have been
      developed. These cages are made of various materials: titanium, stainless steel, carbon fiber
      or polyethylethylketone (Peek). Fusion cages have been quickly integrated into orthopedic
      practice.

      To date, no studies have been conducted that compare the efficacy of nonresorbable and
      bioresorbable fusion cage devices. In this study the surgical and clinical outcomes are
      compared of patients with degenerative lumbar spine disorders who undergo lumbar fusion with
      a nonresorbable versus a bioresorbable fusion cage. Patients with lumbar spinal disorders
      will be recruited from several European centers and randomly allocated to one of the two
      intervention groups. In both treatment groups lumbar spinal fusion is performed using a
      standardized technique.

      Patients will be evaluated during two years post-operatively. During this follow up period,
      the clinical outcome and fusion parameters will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>October 2004</start_date>
  <completion_date>May 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acquired fusion</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical outcome</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and complications</measure>
  </secondary_outcome>
  <enrollment>102</enrollment>
  <condition>Low Back Pain</condition>
  <condition>Spondylolisthesis</condition>
  <condition>Spinal Stenosis</condition>
  <condition>Intervertebral Disc Displacement</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lumbar Interbody Fusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both genders, age between 18 and 70 years

          -  Chronic low back pain (&gt; 3 months) with or without leg pain but no signs of motor loss

          -  Based on clinical history, physical examination, and radiographic signs, pain
             interpreted as emanating from L4-L5 or L5-S1

          -  Symptoms refractory to conservative treatment for at least 3 months

          -  Evidence of degenerative changes at L4-L5 or L5-S1 (spondylosis) on plain radiographs
             and/or CT scan, and/or MRI. The pathology should be predominant on one level.

          -  Single-level Posterior Lumbar Interbody Fusion surgery (PLIF) is indicated by the
             spine surgeon

          -  Additional posterior fixation is mandatory

          -  Use of autograft of the iliac crest is possible

          -  Ability to provide informed consent

        Exclusion Criteria:

          -  Previous lumbar spinal fusion

          -  All other previous spinal surgery except for successful removal of a herniated disc
             more than 2 years before entering the study

          -  Symptomatic degenerative disc disorder at more than one lumbar level

          -  Pregnancy or intention to become pregnant during the two year study

          -  Ongoing psychiatric illness

          -  Evidence of alcohol and/or drug abuse

          -  Inability to complete the questionnaires

          -  Inability to walk independently

          -  Other indications than degenerative spinal disorders including a metabolic bone
             disease, osteoporosis, infection, old fracture, inflammatory process, or neoplasm

          -  Obvious painful and disabling arthritic hip joints
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P.I.J.M. Wuisman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BG Unfallklinik Halle, Klinik für Neurochirurgie</name>
      <address>
        <city>Halle</city>
        <zip>06112 Halle</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Rostock, Neurochirurgie</name>
      <address>
        <city>Rostock</city>
        <zip>18057 Rostock</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>NL-1081HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum</name>
      <address>
        <city>Leiden</city>
        <zip>NL- 2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>Vaccaro AR, Singh K, Haid R, Kitchel S, Wuisman P, Taylor W, Branch C, Garfin S. The use of bioabsorbable implants in the spine. Spine J. 2003 May-Jun;3(3):227-37. Review.</citation>
    <PMID>14589204</PMID>
  </reference>
  <reference>
    <citation>Tunc DC, van Dijk M, Smit T, Higham P, Burger E, Wuisman P. Three-year follow-up of bioabsorbable PLLA cages for lumbar interbody fusion: in vitro and in vivo degradation. Adv Exp Med Biol. 2004;553:243-55.</citation>
    <PMID>15503461</PMID>
  </reference>
  <reference>
    <citation>Smit TH, Müller R, van Dijk M, Wuisman PI. Changes in bone architecture during spinal fusion: three years follow-up and the role of cage stiffness. Spine (Phila Pa 1976). 2003 Aug 15;28(16):1802-8; discussion 1809.</citation>
    <PMID>12923466</PMID>
  </reference>
  <reference>
    <citation>van Dijk M, Smit TH, Arnoe MF, Burger EH, Wuisman PI. The use of poly-L-lactic acid in lumbar interbody cages: design and biomechanical evaluation in vitro. Eur Spine J. 2003 Feb;12(1):34-40. Epub 2002 Sep 6.</citation>
    <PMID>12592545</PMID>
  </reference>
  <reference>
    <citation>van Dijk M, Smit TH, Burger EH, Wuisman PI. Bioabsorbable poly-L-lactic acid cages for lumbar interbody fusion: three-year follow-up radiographic, histologic, and histomorphometric analysis in goats. Spine (Phila Pa 1976). 2002 Dec 1;27(23):2706-14.</citation>
    <PMID>12461397</PMID>
  </reference>
  <reference>
    <citation>Wuisman PI, van Dijk M, Smit TH. Resorbable cages for spinal fusion: an experimental goat model. J Neurosurg. 2002 Nov;97(4 Suppl):433-9.</citation>
    <PMID>12449197</PMID>
  </reference>
  <reference>
    <citation>van Dijk M, Tunc DC, Smit TH, Higham P, Burger EH, Wuisman PI. In vitro and in vivo degradation of bioabsorbable PLLA spinal fusion cages. J Biomed Mater Res. 2002;63(6):752-9.</citation>
    <PMID>12418020</PMID>
  </reference>
  <reference>
    <citation>Wuisman PI, van Dijk M, Smit TH. Resorbable cages for spinal fusion: an experimental goat model. Orthopedics. 2002 Oct;25(10 Suppl):s1141-8.</citation>
    <PMID>12401024</PMID>
  </reference>
  <reference>
    <citation>van Dijk M, Smit TH, Sugihara S, Burger EH, Wuisman PI. The effect of cage stiffness on the rate of lumbar interbody fusion: an in vivo model using poly(l-lactic Acid) and titanium cages. Spine (Phila Pa 1976). 2002 Apr 1;27(7):682-8.</citation>
    <PMID>11923659</PMID>
  </reference>
  <reference>
    <citation>Toth JM, Estes BT, Wang M, Seim HB 3rd, Scifert JL, Turner AS, Cornwall GB. Evaluation of 70/30 poly (L-lactide-co-D,L-lactide) for use as a resorbable interbody fusion cage. J Neurosurg. 2002 Nov;97(4 Suppl):423-32.</citation>
    <PMID>12449196</PMID>
  </reference>
  <reference>
    <citation>Toth JM, Wang M, Scifert JL, Cornwall GB, Estes BT, Seim HB 3rd, Turner AS. Evaluation of 70/30 D,L-PLa for use as a resorbable interbody fusion cage. Orthopedics. 2002 Oct;25(10 Suppl):s1131-40.</citation>
    <PMID>12401023</PMID>
  </reference>
  <reference>
    <citation>Vaccaro AR, Robbins MM, Madigan L, Albert TJ, Smith W, Hilibrand AS. Early findings in a pilot study of anterior cervical fusion in which bioabsorbable interbody spacers were used in the treatment of cervical degenerative disease. Neurosurg Focus. 2004 Mar 15;16(3):E7.</citation>
    <PMID>15198495</PMID>
  </reference>
  <reference>
    <citation>Lippman CR, Hajjar M, Abshire B, Martin G, Engelman RW, Cahill DW. Cervical spine fusion with bioabsorbable cages. Neurosurg Focus. 2004 Mar 15;16(3):E4.</citation>
    <PMID>15198492</PMID>
  </reference>
  <reference>
    <citation>Krijnen MR, Smit TH, Strijkers GJ, Nicolay K, Pouwels PJ, Wuisman PI. The use of high-resolution magnetic resonance imaging for monitoring interbody fusion and bioabsorbable cages: an ex vivo pilot study. Neurosurg Focus. 2004 Mar 15;16(3):E3.</citation>
    <PMID>15198491</PMID>
  </reference>
  <reference>
    <citation>Robbins MM, Vaccaro AR, Madigan L. The use of bioabsorbable implants in spine surgery. Neurosurg Focus. 2004 Mar 15;16(3):E1. Review.</citation>
    <PMID>15198489</PMID>
  </reference>
  <verification_date>March 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2004</study_first_submitted>
  <study_first_submitted_qc>October 29, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2004</study_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <keyword>Spine</keyword>
  <keyword>Lumbar spine</keyword>
  <keyword>Spinal fusion</keyword>
  <keyword>Low back pain</keyword>
  <keyword>Fusion cage</keyword>
  <keyword>Posterior lumbar interbody fusion</keyword>
  <keyword>Bioresorbable</keyword>
  <keyword>Peek</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

